Patrice Fardellone

Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis

J. Timothy Harrington, L.-G. Ste-Marie, Maria Luisa Brandi et al. · Calcified Tissue International · 2004 · 223 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice

Stefano Bombardieri, A. A. Ruiz, Patrice Fardellone et al. · Lara D. Veeken · 2007 · 178 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis

FE Cotté, Patrice Fardellone, François Mercier et al. · Osteoporosis International · 2009 · 138 citations · Full text

Pharmacy, Pharmacotherapy, Pharmaceutical Care +13

Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services

Willem F. Lems, Julien Paccou, Jianfa Zhang et al. · Osteoporosis International · 2021 · 136 citations · Full text

Medicine, Orthopedic Surgery, Radiology +17